CRESY
Cresud
CRESY • NASDAQ
Cresud is a pharmaceutical preparations company trading on NASDAQ, led by CEO Alejandro Gustavo Elsztain.
CEOAlejandro Gustavo Elsztain
Next Earnings
Upcoming earnings announcement for Cresud
Date
Friday, May 8, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q3 2026
Earnings History
Past 11 earnings reports for Cresud
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q1 2026 | $0.42 | — | $239.9M | — | — |
| Sep 4, 2025 | Q4 2025 | $0.99 | — | $197.7M | — | — |
| May 9, 2025 | Q3 2025 | $0.12 | — | $189.3M | — | — |
| Feb 10, 2025 | Q2 2025 | -$0.32 | — | $204.7M | — | — |
| Nov 8, 2024 | Q1 2025 | -$0.71 | — | $222.9M | — | — |
| Sep 9, 2024 | Q4 2024 | $1.00 | — | $294.4M | — | — |
| May 10, 2024 | Q3 2024 | $0.20 | — | $242.0M | — | — |
| Feb 9, 2024 | Q2 2024 | -$0.56 | — | $246.6M | — | — |
| Nov 9, 2023 | Q1 2024 | $1.92 | — | $219.7M | — | — |
| Sep 7, 2023 | Q4 2023 | $1.40 | — | $347.2M | — | — |
| May 11, 2023 | Q3 2023 | $0.57 | — | $148.0M | — | — |